Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_31201 | 73 | 1.53 | Mlig455_045851, Mlig455_045867 | Neo: - Age: Up-Down-Up |
LRRC9 | Mlig455_045851 {REF} {Length: 5484} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.6]; Leucine rich repeat [PF13855.8, score=111.6]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=437, Expect=1e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=73.6, Expect=1e-12]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=7e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=368, Expect=4e-108]} {RNA1509_22179} {RNA1310_1731, RNA1509_22179} {RNA1509_22179, RNA815_589.1} Mlig455_045867 {REF} {Length: 5480} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.3]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.0]; Leucine rich repeat [PF13855.8, score=111.3]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=436, Expect=2e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=74.7, Expect=6e-13]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=8e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=369, Expect=2e-108]} {RNA1509_22179} {RNA1310_1731} {RNA815_589.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -8.071 | 1.349 | 0.04662 | 0.51580 | |
RegionR2 | 3.722 | 1.349 | 0.03453 | 0.21296 | |
RegionR3 | 0.736 | 1.349 | 0.53495 | 1.00000 | |
RegionR4 | -3.159 | 1.349 | 1.00000 | 1.00000 | |
RegionR5 | -0.009 | 1.349 | 0.88674 | 1.00000 | |
RegionR6 | 1.043 | 1.349 | 0.44501 | 1.00000 | |
RegionR7 | 1.289 | 1.349 | 0.48804 | 1.00000 | |
RegionR8 | 4.45 | 1.349 | 0.00278 | 0.09074 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 6.49 | 1.349 | 1.00000 | 1.00000 | |
RegenerationR2 | 2.423 | 1.349 | 0.05661 | 0.39081 | |
RegenerationR3 | 5.512 | 1.349 | 0.00058 | 0.03630 | |
RegenerationR4 | 3.601 | 1.349 | 0.02010 | 0.22385 | |
RegenerationR5 | 3.715 | 1.349 | 0.00546 | 0.13535 | |
RegenerationR6 | 4.19 | 1.349 | 0.00568 | 0.09121 | |
RegenerationBL | 2.908 | 1.349 | 0.04832 | 0.25213 | |
RegenerationTP | 3.83 | 1.349 | 0.00440 | 0.10992 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_31201 | 73 | 1.53 | Mlig455_045851, Mlig455_045867 | Neo: - Age: Up-Down-Up |
LRRC9 | 5 | 1.000 | 1.000 | - | 1.000 | 1.000 | 1.000 | Mlig455_045851 {REF} {Length: 5484} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.6]; Leucine rich repeat [PF13855.8, score=111.6]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=437, Expect=1e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=73.6, Expect=1e-12]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=7e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=368, Expect=4e-108]} {RNA1509_22179} {RNA1310_1731, RNA1509_22179} {RNA1509_22179, RNA815_589.1} Mlig455_045867 {REF} {Length: 5480} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.3]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.0]; Leucine rich repeat [PF13855.8, score=111.3]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=436, Expect=2e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=74.7, Expect=6e-13]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=8e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=369, Expect=2e-108]} {RNA1509_22179} {RNA1310_1731} {RNA815_589.1} |
2. | MligTC455_02323 | 125 | 2.59 | Mlig455_042840 | Neo: - Age: - Region-enriched R7: 3.998/0.00319 |
HRASLS | 1.879 | - | - | - | - | 0.924 | 0.955 | Mlig455_042840 {REF} {Length: 1042} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=47.1]} {Human: ENSG00000127252, HRASLS, HRAS like suppressor, [Score=47.8, Expect=7e-06]} {Mouse: ENSMUSG00000028003, Lrat, lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase), [RH, Score=47.8, Expect=4e-06]} {RNA1310_85008} {RNA815_46214} |
3. | MligTC455_02324 | 121 | 2.51 | Mlig455_045874 | Neo: - Age: - Region-enriched R7: 4.211/0.00373 |
HRASLS | 1.869 | - | - | - | - | 0.916 | 0.953 | Mlig455_045874 {REF} {Length: 1080} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=47.1]} {Human: ENSG00000127252, HRASLS, HRAS like suppressor, [Score=47.8, Expect=7e-06]} {Mouse: ENSMUSG00000028003, Lrat, lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase), [RH, Score=47.4, Expect=5e-06]} {RNA1310_85008} {RNA815_46214} |
4. | MligTC455_36704 | 63 | 1.32 | Mlig455_020575 | Neo: - Age: - Region-enriched R2: 5.118/0.04973 |
1.825 | - | - | - | - | 0.955 | 0.870 | Mlig455_020575 {REF} {Length: 4566} {NoTransDecoderORF} {RNA1509_44743} {RNA1310_5450.1} {RNA815_16253.1} | |
5. | MligTC455_10321 | 235 | 4.89 | Mlig455_004945, Mlig455_035629, Mlig455_055310 | Neo: - Age: - |
1.812 | 0.832 | - | - | - | - | 0.980 | Mlig455_004945 {REF} {Length: 80} {NoTransDecoderORF} {RNA1509_52583} {RNA1310_6592} {RNA815_13363} Mlig455_035629 {REF} {Length: 143} {NoTransDecoderORF} {RNA1509_52583} {RNA1310_6592} {RNA815_13363} Mlig455_055310 {REF} {Length: 2978} {RNA1509_52583} {RNA1310_43983.1} {RNA815_13363} |
|
6. | MligTC455_30420 | 109 | 2.28 | Mlig455_054202, Mlig455_060746 | Neo: - Age: - |
TMEM26 | 1.808 | 0.843 | - | - | - | - | 0.965 | Mlig455_054202 {REF} {Length: 2118} {Pfam: Transmembrane protein 26 [PF09772.11, score=227.2]} {Human: ENSG00000196932, TMEM26, transmembrane protein 26, [Score=126, Expect=7e-33]} {Mouse: ENSMUSG00000060044, Tmem26, transmembrane protein 26, [RH, Score=134, Expect=7e-36]} {Dmel: FBgn0039429, CG14238, [Score=172, Expect=5e-49]} {Celegans: WBGene00022469, Y119C1B.3, [Score=139, Expect=2e-37]} {Smed: dd_Smed_v6_30929_0_1, dd_Smed_v6_30929_0_1, [Score=144, Expect=1e-39]} {RNA1310_35836} {RNA815_14435} Mlig455_060746 {REF} {Length: 3939} {Pfam: Transmembrane protein 26 [PF09772.11, score=226.7]} {Human: ENSG00000196932, TMEM26, transmembrane protein 26, [Score=127, Expect=5e-33]} {Mouse: ENSMUSG00000060044, Tmem26, transmembrane protein 26, [RH, Score=136, Expect=1e-36]} {Dmel: FBgn0039429, CG14238, [Score=171, Expect=8e-49]} {Celegans: WBGene00022469, Y119C1B.3, [Score=139, Expect=2e-37]} {Smed: dd_Smed_v6_30929_0_1, dd_Smed_v6_30929_0_1, [Score=144, Expect=1e-39]} {RNA1310_35836} {RNA815_14435} |
7. | MligTC455_28655 | 49 | 1.03 | Mlig455_048319 | Neo: - |
RNF213 | 1.774 | - | - | - | - | 0.795 | 0.979 | Mlig455_048319 {REF} {Length: 12875} {Pfam: ATPase family associated with various cellular activities (AAA) [PF00004.31, score=25.3]; AAA domain (dynein-related subfamily) [PF07728.16, score=23.1]} {Human: ENSG00000173821, RNF213, ring finger protein 213, [Score=329, Expect=5e-89]} {Mouse: ENSMUSG00000070327, Rnf213, ring finger protein 213, [Score=319, Expect=3e-86]} {RNA1509_30363} {RNA1310_550} {RNA815_15} |
8. | MligTC455_11926 | 101 | 2.11 | Mlig455_021319 | Neo: - Age: - Region-enriched R7: 4.905/0.00107 |
1.723 | 0.769 | - | - | - | - | 0.954 | Mlig455_021319 {REF} {Length: 2758} {Pfam: Mab-21 protein [PF03281.16, score=23.9]} {RNA1509_41055} {RNA1310_11481.1} {RNA815_44675} | |
9. | MligTC455_47787 | 741 | 15.44 | Mlig455_059451 | Neo: - Age: logFC(26M/2M)=-0.505 Region-enriched R8: 1.658/0.04622 |
1.718 | 0.757 | - | - | - | - | 0.961 | Mlig455_059451 {REF} {Length: 2112} {RNA1509_40006} {RNA1310_14082, RNA1509_40006} {RNA1509_40006, RNA815_12176} | |
10. | MligTC455_18799 | 47 | 0.98 | Mlig455_031256, Mlig455_031302 | Neo: - Age: - |
1.701 | - | - | - | 0.716 | - | 0.985 | Mlig455_031256 {REF} {Length: 1098} Mlig455_031302 {REF} {Length: 1102} |
|
11. | MligTC455_26668 | 406 | 8.46 | Mlig455_011365 | Neo: - Age: - Regeneration-upregulated BL: 6.270 Regeneration-enriched BL: 6.270 |
1.692 | - | - | - | - | 0.713 | 0.979 | Mlig455_011365 {REF} {Length: 3699} {Pfam: Protein of unknown function (DUF1104) [PF06518.13, score=20.7]} {RNA1509_40399} {RNA1310_340.1} {RNA815_1857} | |
12. | MligTC455_30121 | 227 | 4.74 | Mlig455_049656 | Neo: - |
ZBED1 | 1.691 | - | - | - | - | 0.730 | 0.961 | Mlig455_049656 {REF} {Length: 5385} {TRANSSPLICED} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=44.1]; BED zinc finger [PF02892.17, score=30.7]} {Human: ENSG00000214717, ZBED1, zinc finger BED-type containing 1, [Score=89.0, Expect=1e-17]} {Mouse: ENSMUSG00000094410, Gm38394, predicted gene, 38394, [Score=59.3, Expect=1e-08]; ENSMUSG00000102049, Zbed6, zinc finger, BED type containing 6, [Score=59.3, Expect=1e-08]} {Smed: dd_Smed_v6_18427_0_1, dd_Smed_v6_18427_0_1, [Score=49.7, Expect=4e-06]} {RNA1509_6537} {RNA1310_5792, RNA1509_6537} {RNA1509_6537, RNA815_1502} |
13. | MligTC455_30120 | 632 | 13.16 | Mlig455_034161, Mlig455_042293, Mlig455_047751 | Neo: - Age: logFC(26M/2M)=0.780 Region-enriched R4: 1.642/0.03663 |
ZBED1 | 1.683 | - | - | - | - | 0.727 | 0.956 | Mlig455_034161 {REF} {Length: 2933} {TRANSSPLICED} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=44.1]; BED zinc finger [PF02892.17, score=30.7]} {Human: ENSG00000214717, ZBED1, zinc finger BED-type containing 1, [Score=89.0, Expect=1e-17]} {Mouse: ENSMUSG00000094410, Gm38394, predicted gene, 38394, [Score=59.3, Expect=1e-08]; ENSMUSG00000102049, Zbed6, zinc finger, BED type containing 6, [Score=59.3, Expect=1e-08]} {Smed: dd_Smed_v6_18427_0_1, dd_Smed_v6_18427_0_1, [Score=49.7, Expect=4e-06]} {RNA1509_6537} {RNA1310_5792} {RNA815_1502} Mlig455_042293 {REF} {Length: 2933} {TRANSSPLICED} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=44.1]; BED zinc finger [PF02892.17, score=30.7]} {Human: ENSG00000214717, ZBED1, zinc finger BED-type containing 1, [Score=89.0, Expect=1e-17]} {Mouse: ENSMUSG00000094410, Gm38394, predicted gene, 38394, [Score=59.3, Expect=1e-08]; ENSMUSG00000102049, Zbed6, zinc finger, BED type containing 6, [Score=59.3, Expect=1e-08]} {Smed: dd_Smed_v6_18427_0_1, dd_Smed_v6_18427_0_1, [Score=49.7, Expect=4e-06]} {RNA1509_6537} {RNA1310_5792} {RNA815_1502} Mlig455_047751 {REF} {Length: 2933} {TRANSSPLICED} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=44.1]; BED zinc finger [PF02892.17, score=30.7]} {Human: ENSG00000214717, ZBED1, zinc finger BED-type containing 1, [Score=89.0, Expect=1e-17]} {Mouse: ENSMUSG00000094410, Gm38394, predicted gene, 38394, [Score=59.3, Expect=1e-08]; ENSMUSG00000102049, Zbed6, zinc finger, BED type containing 6, [Score=59.3, Expect=1e-08]} {Smed: dd_Smed_v6_18427_0_1, dd_Smed_v6_18427_0_1, [Score=49.7, Expect=4e-06]} {RNA1509_6537} {RNA1310_5792} {RNA815_1502} |
14. | MligTC455_18401 | 44 | 0.92 | Mlig455_060625 | Neo: - Age: - |
1.676 | - | - | - | - | 0.709 | 0.967 | Mlig455_060625 {REF} {Length: 2190} {NoTransDecoderORF} {RNA1509_38113} {RNA1310_33283} {RNA815_55541} | |
15. | MligTC455_33068 | 138 | 2.87 | Mlig455_011936 | Neo: - Age: - |
1.674 | - | - | - | - | 0.954 | 0.720 | Mlig455_011936 {REF} {Length: 1402} {TRANSSPLICED} {RNA1509_20571} {RNA1310_38731} {RNA815_19943} | |
16. | MligTC455_08889 | 26 | 0.54 | Mlig455_054256 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_054256 {REF} {Length: 1360} {NoTransDecoderORF} {RNA1509_50721} {RNA1310_33163} {RNA815_21535} | |
17. | MligTC455_16032 | 77 | 1.61 | Mlig455_037337 | Neo: Irradiation |
0.98 | - | - | - | - | - | 0.980 | Mlig455_037337 {REF} {Length: 3079} {Pfam: Neuralized [PF07177.14, score=30.4]} {RNA1310_49372} | |
18. | MligTC455_10651 | 37 | 0.76 | Mlig455_050743 | Neo: - Age: - |
0.976 | - | - | - | - | 0.976 | - | Mlig455_050743 {REF} {Length: 486} {NoTransDecoderORF} {RNA1310_45533} | |
19. | MligTC455_24828 | 185 | 3.85 | Mlig455_017886 | Neo: - Age: - |
ADPRHL2 | 0.976 | - | - | - | 0.976 | - | - | Mlig455_017886 {REF} {Length: 2559} {TRANSSPLICED} {Pfam: ADP-ribosylglycohydrolase [PF03747.16, score=159.0]} {Human: ENSG00000116863, ADPRHL2, ADP-ribosylhydrolase like 2, [RH, Score=183, Expect=7e-54]} {Mouse: ENSMUSG00000042558, Adprhl2, ADP-ribosylhydrolase like 2, [RH, Score=184, Expect=2e-54]} {RNA1509_24320, RNA1509_51846, RNA1509_7861} {RNA1310_12044.2, RNA1509_51846, RNA1509_7861} {RNA1509_51846, RNA1509_7861, RNA815_33135} |
20. | MligTC455_46554 | 47 | 0.97 | Mlig455_038253 | Neo: - Age: logFC(26M/2M)=-0.562 |
0.976 | - | - | - | - | - | 0.976 | Mlig455_038253 {REF} {Length: 1890} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=60.6]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=94.4, Expect=7e-24]} {RNA1310_40614} {RNA815_32173} | |
21. | MligTC455_23808 | 31 | 0.65 | Mlig455_059306 | Neo: - Age: Down-Down-Up |
0.975 | - | - | - | - | - | 0.975 | Mlig455_059306 {REF} {Length: 1845} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=30.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042} | |
22. | MligTC455_08322 | 31 | 0.65 | Mlig455_052171, Mlig455_060718 | Neo: - Age: - |
ROMO1 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_052171 {REF} {Length: 563} {Pfam: Reactive mitochondrial oxygen species modulator 1 [PF10247.11, score=80.5]} {Human: ENSG00000125995, ROMO1, reactive oxygen species modulator 1, [RH, Score=86.7, Expect=3e-23]} {Mouse: ENSMUSG00000067847, Romo1, reactive oxygen species modulator 1, [RH, Score=86.7, Expect=2e-23]} {Dmel: FBgn0036488, CG6878, [RH, Score=87.8, Expect=4e-24]} {Smed: dd_Smed_v6_691_0_1, dd_Smed_v6_691_0_1, [RH, Score=76.6, Expect=6e-20]} {RNA1509_47263, RNA1509_55753} {RNA1310_24276, RNA1509_55753} {RNA1509_55753, RNA815_33160} Mlig455_060718 {REF} {Length: 502} {TRANSSPLICED} {Pfam: Reactive mitochondrial oxygen species modulator 1 [PF10247.11, score=80.5]} {Human: ENSG00000125995, ROMO1, reactive oxygen species modulator 1, [RH, Score=86.7, Expect=3e-23]} {Mouse: ENSMUSG00000067847, Romo1, reactive oxygen species modulator 1, [RH, Score=86.7, Expect=2e-23]} {Dmel: FBgn0036488, CG6878, [RH, Score=87.8, Expect=4e-24]} {Smed: dd_Smed_v6_691_0_1, dd_Smed_v6_691_0_1, [RH, Score=76.6, Expect=6e-20]} {RNA1509_47263} {RNA1310_24276, RNA1509_47263} {RNA1509_47263, RNA815_33160} |
23. | MligTC455_57738 | 33 | 0.69 | Mlig455_050734 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_050734 {REF} {Length: 453} {NoTransDecoderORF} {RNA1310_45533} | |
24. | MligTC455_09763 | 31 | 0.65 | Mlig455_042548 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_042548 {REF} {Length: 2075} {RNA1509_32911} {RNA1310_1680} {RNA815_1218} | |
25. | MligTC455_24711 | 46 | 0.96 | Mlig455_015705 | Neo: - Age: - Regeneration-upregulated BL: 6.967 Regeneration-enriched BL: 6.967 |
0.972 | - | - | - | - | - | 0.972 | Mlig455_015705 {REF} {Length: 1380} {NoTransDecoderORF} {RNA1509_40708} {RNA1310_77515} {RNA815_26884} | |
26. | MligTC455_21582 | 28 | 0.58 | Mlig455_048795 | Neo: - Age: - |
0.97 | - | - | - | - | - | 0.970 | Mlig455_048795 {REF} {Length: 582} {NoTransDecoderORF} | |
27. | MligTC455_25287 | 78 | 1.62 | Mlig455_016988, Mlig455_021241, Mlig455_069255 | Neo: - |
FCN2 | 0.968 | - | - | - | - | - | 0.968 | Mlig455_016988 {REF} {Length: 1045} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=147.6]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=141, Expect=1e-39]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=134, Expect=1e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=134, Expect=8e-36]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [RH, Score=133, Expect=1e-36]} {Dmel: FBgn0030163, CG1791, [RH, Score=120, Expect=9e-32]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=105, Expect=2e-25]} {RNA1310_48119} {RNA815_52558} Mlig455_021241 {REF} {Length: 1723} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=97.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=104, Expect=2e-24]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=100, Expect=4e-22]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=102, Expect=8e-24]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=101, Expect=1e-22]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=99.0, Expect=5e-22]; ENSMUSG00000026841, Fibcd1, fibrinogen C domain containing 1, [Score=97.1, Expect=2e-21]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=97.1, Expect=3e-21]} {Dmel: FBgn0030163, CG1791, [Score=97.4, Expect=4e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.6, Expect=1e-18]} {RNA1509_12256} {RNA1310_326} {RNA815_351.1} Mlig455_069255 {REF} {Length: 8909} {RNA1509_33647, RNA1509_36216} {RNA1310_15325.1, RNA1509_33647, RNA1509_36216} {RNA1509_33647, RNA1509_36216, RNA815_10965} |
28. | MligTC455_06484 | 46 | 0.96 | Mlig455_061537 | Neo: - Age: - |
0.967 | - | - | - | - | - | 0.967 | Mlig455_061537 {REF} {Length: 542} {NoTransDecoderORF} {RNA1310_116180} | |
29. | MligTC455_12660 | 30 | 0.62 | Mlig455_061006 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_061006 {REF} {Length: 1691} {RNA1310_9613} | |
30. | MligTC455_00184 | 8 | 0.17 | Mlig455_058285 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_058285 {REF} {Length: 297} {NoTransDecoderORF} | |
31. | MligTC455_03357 | 7 | 0.14 | Mlig455_041258 | Neo: - Age: - |
CCDC15 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_041258 {REF} {Length: 1532} {Human: ENSG00000149548, CCDC15, coiled-coil domain containing 15, [Score=78.6, Expect=1e-14]} {Mouse: ENSMUSG00000026090, 2010300C02Rik, RIKEN cDNA 2010300C02 gene, [Score=69.3, Expect=6e-12]} {Dmel: FBgn0053265, Muc68E, Mucin 68E, [Score=104, Expect=3e-23]} {RNA1310_54182} {RNA815_44634} |
32. | MligTC455_17040 | 75 | 1.57 | Mlig455_029809 | Neo: - Age: - Region-enriched R7: 3.328/0.01605 |
ARHGAP39 | 0.966 | - | - | - | - | - | 0.966 | Mlig455_029809 {REF} {Length: 3933} {Pfam: MyTH4 domain [PF00784.19, score=92.2]; RhoGAP domain [PF00620.29, score=84.9]} {Human: ENSG00000147799, ARHGAP39, Rho GTPase activating protein 39, [Score=266, Expect=1e-79]} {Mouse: ENSMUSG00000033697, Arhgap39, Rho GTPase activating protein 39, [Score=265, Expect=4e-79]} {Dmel: FBgn0038853, RhoGAP93B, Rho GTPase activating protein at 93B, [Score=221, Expect=1e-63]} {Celegans: WBGene00022365, Y92H12BL.4, [Score=149, Expect=1e-40]} {Smed: dd_Smed_v6_5836_0_1, dd_Smed_v6_5836_0_1, [Score=125, Expect=4e-31]} {RNA1310_44535} {RNA815_34943} |
33. | MligTC455_09301 | 26 | 0.55 | Mlig455_011440 | Neo: - Age: - Regeneration-upregulated BL: 7.313 Regeneration-enriched BL: 7.313 |
0.965 | - | - | - | - | - | 0.965 | Mlig455_011440 {REF} {Length: 331} {NoTransDecoderORF} {RNA1509_58496} {RNA1310_68696} {RNA815_38510} | |
34. | MligTC455_19124 | 68 | 1.41 | Mlig455_056714 | Neo: - Age: Up-Down-Up |
NPFFR1 | 0.965 | - | - | - | - | - | 0.965 | Mlig455_056714 {REF} {Length: 3702} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=113.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=90.1, Expect=1e-18]; ENSG00000137252, HCRTR2, hypocretin receptor 2, [Score=87.8, Expect=6e-18]} {Mouse: ENSMUSG00000038071, Npy6r, neuropeptide Y receptor Y6, [Score=105, Expect=2e-24]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=131, Expect=7e-33]} {Celegans: WBGene00003808, npr-2, NeuroPeptide Receptor family, [Score=100, Expect=1e-22]} {Smed: dd_Smed_v6_26109_0_1, dd_Smed_v6_26109_0_1, [RH, Score=210, Expect=4e-61]} {RNA1509_34547} {RNA1310_9062, RNA1509_34547} {RNA1509_34547, RNA815_6805} |
35. | MligTC455_49527 | 147 | 3.06 | Mlig455_027843 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_027843 {REF} {Length: 1796} {RNA1509_15103} {RNA1310_101911} {RNA815_59080} | |
36. | MligTC455_11444 | 25 | 0.53 | Mlig455_066854 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_066854 {REF} {Length: 845} {NoTransDecoderORF} {RNA1310_141915} | |
37. | MligTC455_28153 | 87 | 1.82 | Mlig455_023355 | Neo: - Age: Down-Up-Down |
0.964 | - | - | - | - | - | 0.964 | Mlig455_023355 {REF} {Length: 2641} {Pfam: HTH domain in Mos1 transposase [PF17906.3, score=23.0]} {RNA1509_36436} {RNA1310_24275.2} {RNA815_11419.1} | |
38. | MligTC455_36276 | 11 | 0.23 | Mlig455_008174, Mlig455_069596 | Neo: - Age: - |
TNKS | 0.964 | - | - | - | - | 0.964 | - | Mlig455_008174 {REF} {Length: 3526} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=41.1]; Ankyrin repeat [PF00023.32, score=37.0]; Ankyrin repeat [PF13606.8, score=36.7]; Ankyrin repeats (many copies) [PF13857.8, score=26.0]; Mab-21 protein [PF03281.16, score=21.3]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=62.4, Expect=5e-09]; ENSG00000285372, AC270292.3, tankyrase, [Score=62.0, Expect=6e-09]; ENSG00000170921, TANC2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=62.0, Expect=6e-09]} {Mouse: ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=62.4, Expect=3e-09]; ENSMUSG00000053580, Tanc2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=60.8, Expect=4e-09]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=55.5, Expect=3e-07]} {Smed: dd_Smed_v6_21003_0_1, dd_Smed_v6_21003_0_1, [Score=54.7, Expect=3e-07]} {RNA1310_61630} {RNA815_31743} Mlig455_069596 {REF} {Length: 3865} {Pfam: Mab-21 protein [PF03281.16, score=25.9]; Ankyrin repeat [PF00023.32, score=20.8]; Ankyrin repeats (3 copies) [PF12796.9, score=19.8]; Ankyrin repeat [PF13606.8, score=18.9]} {RNA1509_19198} {RNA1310_61630} {RNA815_31743} |
39. | MligTC455_50390 | 19 | 0.4 | Mlig455_016912 | Neo: - Age: - |
CHRNA3 | 0.964 | - | - | - | - | - | 0.964 | Mlig455_016912 {REF} {Length: 2944} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=242.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=157.8]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=326, Expect=7e-105]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=317, Expect=2e-101]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=317, Expect=2e-101]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=313, Expect=5e-100]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=320, Expect=8e-103]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=317, Expect=1e-101]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=315, Expect=2e-101]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=304, Expect=8e-97]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=347, Expect=1e-112]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [RH, Score=307, Expect=1e-98]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [RH, Score=539, Expect=0.0]} {RNA1310_33221} {RNA815_23594.2} |
40. | MligTC455_10265 | 15 | 0.31 | Mlig455_050250 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_050250 {REF} {Length: 1184} | |
41. | MligTC455_20478 | 52 | 1.08 | Mlig455_031423 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_031423 {REF} {Length: 1562} {NoTransDecoderORF} {RNA1310_4910} | |
42. | MligTC455_28130 | 73 | 1.52 | Mlig455_017884 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_017884 {REF} {Length: 3157} {NoTransDecoderORF} {RNA1509_13222} {RNA1310_34828.2} {RNA815_11419.1} | |
43. | MligTC455_36185 | 71 | 1.48 | Mlig455_035985 | Neo: - Age: - |
KCNH7 | 0.963 | - | - | - | - | - | 0.963 | Mlig455_035985 {REF} {Length: 3355} {Pfam: Ion transport protein [PF00520.33, score=118.6]; Ion channel [PF07885.18, score=46.2]; PAS domain [PF13426.9, score=44.5]; Cyclic nucleotide-binding domain [PF00027.31, score=43.8]; PAS fold [PF00989.27, score=22.5]; PAS fold [PF08447.14, score=21.9]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=795, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=786, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=773, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=795, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=794, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=774, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=714, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=775, Expect=0.0]} {RNA1509_16542} {RNA1310_5129.1} {RNA815_4089.1} |
44. | MligTC455_28340 | 55 | 1.14 | Mlig455_034493, Mlig455_038767, Mlig455_066245 | Neo: - Age: Up-Down-Up Region-enriched R2: 4.182/0.03406 |
CHRNB3, PCDH9 | 0.962 | - | - | - | - | - | 0.962 | Mlig455_034493 {REF} {Length: 1601} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=158.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=91.2]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=204, Expect=4e-59]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=202, Expect=4e-58]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=195, Expect=1e-55]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=194, Expect=2e-55]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=194, Expect=3e-54]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=206, Expect=5e-60]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=200, Expect=2e-57]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=190, Expect=8e-54]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=185, Expect=1e-52]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=370, Expect=4e-122]} {RNA1509_55679} {RNA1310_29798} {RNA815_45190} Mlig455_038767 {REF} {Length: 4472} {Pfam: Cadherin domain [PF00028.19, score=325.9]; Cadherin-like [PF16184.7, score=44.8]; Cadherin-like [PF08266.14, score=40.4]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [RH, Score=339, Expect=1e-98]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [RH, Score=335, Expect=2e-97]} {Dmel: FBgn0024836, stan, starry night, [Score=248, Expect=4e-67]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=214, Expect=3e-56]} {Smed: dd_Smed_v6_11633_0_1, dd_Smed_v6_11633_0_1, [RH, Score=355, Expect=2e-105]} {RNA1509_51596} {RNA1310_4295, RNA1509_51596} {RNA1509_51596, RNA815_10391} Mlig455_066245 {REF} {Length: 3076} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=159.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.6]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=208, Expect=1e-60]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=207, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=202, Expect=4e-57]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=202, Expect=2e-58]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=3e-57]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=198, Expect=1e-56]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=210, Expect=2e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=206, Expect=1e-59]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=201, Expect=2e-56]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=201, Expect=4e-58]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=201, Expect=9e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=187, Expect=3e-53]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=424, Expect=6e-143]} {RNA1509_55679} {RNA1310_29798, RNA1509_55679} {RNA1509_55679, RNA815_45190} |
45. | MligTC455_16142 | 67 | 1.41 | Mlig455_028937 | Neo: - Age: - |
0.961 | - | - | - | - | - | 0.961 | Mlig455_028937 {REF} {Length: 2115} {NoTransDecoderORF} {RNA1509_53775} {RNA1310_26215.1, RNA1509_53775} {RNA1509_53775, RNA815_54266} | |
46. | MligTC455_17524 | 186 | 3.87 | Mlig455_019598 | Neo: - Age: - |
0.961 | - | - | - | - | - | 0.961 | Mlig455_019598 {REF} {Length: 2178} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=88.0]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=50.1, Expect=3e-06]} {Smed: dd_Smed_v6_15195_0_1, dd_Smed_v6_15195_0_1, [Score=56.2, Expect=2e-08]} {RNA1509_35331} {RNA1310_2795.1} {RNA815_4169} | |
47. | MligTC455_25309 | 27 | 0.56 | Mlig455_007405 | Neo: - Age: - |
0.961 | - | - | - | - | - | 0.961 | Mlig455_007405 {REF} {Length: 5652} {RNA1509_20101} {RNA1310_66411} {RNA815_42952} | |
48. | MligTC455_34838 | 79 | 1.65 | Mlig455_055037, Mlig455_055054 | Neo: - Age: logFC(26M/2M)=-0.508 |
MAN1A2, MAN1C1 | 0.961 | - | - | - | - | - | 0.961 | Mlig455_055037 {REF} {Length: 2154} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=152.3]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=97.1, Expect=8e-23]; ENSG00000177239, MAN1B1, mannosidase alpha class 1B member 1, [Score=94.7, Expect=7e-22]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=94.0, Expect=3e-22]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=97.1, Expect=7e-23]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=95.9, Expect=2e-22]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=82.8, Expect=5e-18]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=77.0, Expect=3e-16]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=88.2, Expect=3e-20]} {RNA1509_49063} {RNA1310_10155.1} {RNA815_4503.1} Mlig455_055054 {REF} {Length: 2620} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=372.1]} {Human: ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=254, Expect=1e-76]; ENSG00000111885, MAN1A1, mannosidase alpha class 1A member 1, [Score=242, Expect=9e-72]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=256, Expect=2e-77]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=248, Expect=3e-74]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=239, Expect=1e-71]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=267, Expect=4e-82]} {RNA1509_40257, RNA1509_47963} {RNA1310_10155.1, RNA1509_47963} {RNA1509_47963, RNA815_4503.1} |
49. | MligTC455_08216 | 34 | 0.7 | Mlig455_009138 | Neo: - Age: - |
0.96 | - | - | - | - | - | 0.960 | Mlig455_009138 {REF} {Length: 379} {NoTransDecoderORF} {RNA1310_66482.1} {RNA815_62564} | |
50. | MligTC455_08369 | 90 | 1.89 | Mlig455_056096 | Neo: - Age: - |
GFI1B | 0.96 | - | - | - | - | 0.960 | - | Mlig455_056096 {REF} {Length: 1035} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=57.3]; Zinc-finger double domain [PF13465.8, score=52.1]; C2H2-type zinc finger [PF13894.8, score=46.3]} {Human: ENSG00000165702, GFI1B, growth factor independent 1B transcriptional repressor, [Score=118, Expect=2e-30]; ENSG00000162676, GFI1, growth factor independent 1 transcriptional repressor, [Score=116, Expect=2e-29]} {Mouse: ENSMUSG00000026815, Gfi1b, growth factor independent 1B, [Score=119, Expect=5e-31]; ENSMUSG00000029275, Gfi1, growth factor independent 1 transcription repressor, [Score=117, Expect=1e-29]} {Dmel: FBgn0051632, sens-2, senseless-2, [Score=119, Expect=6e-30]} {Celegans: WBGene00003909, pag-3, Zinc finger protein PAG-3, [Score=121, Expect=3e-32]} {Smed: dd_Smed_v6_14824_0_1, dd_Smed_v6_14824_0_1, [Score=122, Expect=2e-32]} {RNA1310_33821.1} {RNA815_26811} |
51. | MligTC455_16176 | 76 | 1.58 | Mlig455_048486 | Neo: Int S/G2/M Age: - |
GCM1 | 0.96 | - | - | - | - | - | 0.960 | Mlig455_048486 {REF} {Length: 2372} {Pfam: GCM motif protein [PF03615.17, score=223.0]} {Human: ENSG00000137270, GCM1, glial cells missing homolog 1, [RH, Score=197, Expect=3e-57]; ENSG00000124827, GCM2, glial cells missing homolog 2, [RH, Score=191, Expect=2e-54]} {Mouse: ENSMUSG00000023333, Gcm1, glial cells missing homolog 1, [RH, Score=192, Expect=1e-55]; ENSMUSG00000021362, Gcm2, glial cells missing homolog 2, [RH, Score=189, Expect=1e-53]} {Dmel: FBgn0014179, gcm, glial cells missing, [RH, Score=230, Expect=2e-69]} {Smed: dd_Smed_v6_15107_0_1, dd_Smed_v6_15107_0_1, [RH, Score=186, Expect=3e-54]} {RNA1509_58813} {RNA1310_66943} {RNA815_43872} |
52. | MligTC455_18991 | 10967 | 228.47 | Mlig455_037440, Mlig455_037464, Mlig455_037503 | Neo: - Age: logFC(26M/2M)=-0.211 Regeneration-upregulated BL: 1.902 Regeneration-enriched BL: 1.902 |
CHRNA6 | 0.96 | - | - | - | - | - | 0.960 | Mlig455_037440 {REF} {Length: 2692} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=70.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=47.1]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=117, Expect=2e-28]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=112, Expect=5e-27]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=108, Expect=4e-25]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=108, Expect=2e-25]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=112, Expect=1e-26]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=110, Expect=3e-26]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=113, Expect=2e-27]} {RNA1509_24940, RNA1509_3092} {RNA1310_30196.2, RNA1509_24940} {RNA1509_24940, RNA815_25568} Mlig455_037464 {REF} {Length: 2686} {RNA1509_3092} {RNA1310_30196.2} {RNA815_6516} Mlig455_037503 {REF} {Length: 1172} {RNA1509_3092} {RNA1310_28554} {RNA815_6516} |
53. | MligTC455_25374 | 428 | 8.91 | Mlig455_036389, Mlig455_036390, Mlig455_036391, Mlig455_054557 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=1.690 Regeneration-upregulated BL: 5.459 Regeneration-enriched BL: 5.459 |
0.96 | - | - | - | - | - | 0.960 | Mlig455_036389 {REF} {Length: 860} {NoTransDecoderORF} {RNA1509_40044} {RNA1310_33232} {RNA815_16463} Mlig455_036390 {REF} {Length: 5024} {RNA1509_54862} {RNA1310_31416} {RNA815_5170.1} Mlig455_036391 {REF} {Length: 3445} {RNA1509_54862} {RNA1310_31416} {RNA815_5170.1} Mlig455_054557 {REF} {Length: 6330} {RNA1509_54862} {RNA1310_31416} {RNA815_5170.1} |
|
54. | MligTC455_32436 | 43 | 0.91 | Mlig455_025074 | Neo: - Age: - |
0.96 | - | - | - | - | - | 0.960 | Mlig455_025074 {REF} {Length: 2851} {RNA1509_1845} {RNA1310_50.1} {RNA815_5933} | |
55. | MligTC455_31325 | 78 | 1.62 | Mlig455_026709, Mlig455_044580, Mlig455_050736, Mlig455_050745 | Neo: - Age: - |
0.959 | - | - | - | - | - | 0.959 | Mlig455_026709 {REF} {Length: 5107} {TRANSSPLICED} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=119.6]; Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=19.1]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=65.1, Expect=2e-12]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} Mlig455_044580 {REF} {Length: 2183} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=80.6]} {RNA1509_47056} {RNA1310_3828} {RNA815_6291.1} Mlig455_050736 {REF} {Length: 1564} {TRANSSPLICED} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=121.6]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=65.9, Expect=7e-13]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_15609} Mlig455_050745 {REF} {Length: 1565} {TRANSSPLICED} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=121.6]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=65.9, Expect=7e-13]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_15609} |
|
56. | MligTC455_30249 | 100 | 2.09 | Mlig455_009659, Mlig455_048381 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_009659 {REF} {Length: 3024} {Pfam: Primase C terminal 2 (PriCT-2) [PF08707.13, score=46.3]} {RNA1509_20194} {RNA1310_3607.1} {RNA815_37227} Mlig455_048381 {REF} {Length: 832} {RNA1509_33034} {RNA1310_614.1} {RNA815_31436} |
|
57. | MligTC455_34192 | 134 | 2.8 | Mlig455_022589 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_022589 {REF} {Length: 1896} {RNA1509_34101} {RNA1310_46799} {RNA815_22648} | |
58. | MligTC455_29145 | 72 | 1.51 | Mlig455_014865 | Neo: - Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_014865 {REF} {Length: 3483} {RNA1509_13072} {RNA1310_989.1} {RNA815_1327.1} | |
59. | MligTC455_30270 | 406 | 8.46 | Mlig455_012719, Mlig455_044289 | Neo: Int S/G2/M Age: - Regeneration-upregulated BL: 4.823 Regeneration-enriched BL: 4.823 |
0.957 | - | - | - | - | - | 0.957 | Mlig455_012719 {REF} {Length: 392} {RNA1509_16349} {RNA1310_2575} Mlig455_044289 {REF} {Length: 4784} {RNA1509_16349} {RNA1310_2575} {RNA815_3500.1} |
|
60. | MligTC455_36275 | 17 | 0.36 | Mlig455_008212 | Neo: - Age: Up-Down-Down |
0.957 | - | - | - | - | 0.957 | - | Mlig455_008212 {REF} {Length: 4302} {Pfam: Mab-21 protein [PF03281.16, score=47.1]} {RNA1509_19198} {RNA1310_46396} {RNA815_31743} | |
61. | MligTC455_39057 | 57 | 1.18 | Mlig455_013966 | Neo: Int S/G2/M Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_013966 {REF} {Length: 1262} {NoTransDecoderORF} {RNA1310_104321} | |
62. | MligTC455_44993 | 102 | 2.13 | Mlig455_068082 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.499 Region-enriched R4: 3.035/0.03492 |
MEN1 | 0.957 | - | - | - | - | - | 0.957 | Mlig455_068082 {REF} {Length: 4679} {TRANSSPLICED} {Pfam: Menin [PF05053.15, score=359.0]} {Human: ENSG00000133895, MEN1, menin 1, [RH, Score=259, Expect=6e-77]} {Mouse: ENSMUSG00000024947, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]; ENSMUSG00000106695, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]} {Dmel: FBgn0031885, Mnn1, Menin 1, [RH, Score=219, Expect=4e-61]} {Smed: dd_Smed_v6_11544_0_1, dd_Smed_v6_11544_0_1, [RH, Score=206, Expect=2e-56]} {RNA1509_25186} {RNA1310_10581.1} {RNA815_3602} |
63. | MligTC455_45063 | 105 | 2.19 | Mlig455_045829, Mlig455_045845, Mlig455_045862 | Neo: - Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_045829 {REF} {Length: 4186} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045845 {REF} {Length: 3433} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.9]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=101, Expect=1e-22]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045862 {REF} {Length: 3524} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1, RNA1509_43949} {RNA1509_43949, RNA815_26865} |
|
64. | MligTC455_24621 | 43 | 0.9 | Mlig455_034366 | Neo: - Age: - |
0.956 | - | - | - | - | - | 0.956 | Mlig455_034366 {REF} {Length: 575} {NoTransDecoderORF} | |
65. | MligTC455_28129 | 100 | 2.08 | Mlig455_006881 | Neo: - Age: - |
0.956 | - | - | - | - | - | 0.956 | Mlig455_006881 {REF} {Length: 3777} {NoTransDecoderORF} {RNA1509_13222} {RNA1310_34828.2} {RNA815_11419.1} | |
66. | MligTC455_42418 | 64 | 1.33 | Mlig455_063557 | Neo: - Age: - |
SCNN1G | 0.956 | - | - | - | - | - | 0.956 | Mlig455_063557 {REF} {Length: 3686} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=197.1]} {Human: ENSG00000166828, SCNN1G, sodium channel epithelial 1 gamma subunit, [Score=75.5, Expect=1e-13]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=53.9, Expect=4e-07]; ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=52.0, Expect=1e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=56.6, Expect=3e-08]} {Smed: dd_Smed_v6_18385_0_1, dd_Smed_v6_18385_0_1, [Score=318, Expect=6e-101]} {RNA1310_46167} {RNA815_32816} |
67. | MligTC455_44281 | 456 | 9.5 | Mlig455_068996 | Neo: - Age: - |
ANPEP | 0.956 | - | - | - | - | - | 0.956 | Mlig455_068996 {REF} {Length: 3001} {Pfam: Peptidase family M1 domain [PF01433.22, score=209.7]; ERAP1-like C-terminal domain [PF11838.10, score=183.2]; Peptidase M1 N-terminal domain [PF17900.3, score=52.5]} {Human: ENSG00000166825, ANPEP, alanyl aminopeptidase, membrane, [Score=234, Expect=6e-66]; ENSG00000141279, NPEPPS, aminopeptidase puromycin sensitive, [Score=232, Expect=2e-65]; ENSG00000138792, ENPEP, glutamyl aminopeptidase, [Score=229, Expect=2e-64]; ENSG00000164308, ERAP2, endoplasmic reticulum aminopeptidase 2, [Score=228, Expect=9e-64]; ENSG00000164307, ERAP1, endoplasmic reticulum aminopeptidase 1, [Score=227, Expect=2e-63]} {Mouse: ENSMUSG00000001441, Npepps, aminopeptidase puromycin sensitive, [Score=232, Expect=4e-67]; ENSMUSG00000023845, Lnpep, leucyl/cystinyl aminopeptidase, [Score=226, Expect=5e-63]; ENSMUSG00000028024, Enpep, glutamyl aminopeptidase, [Score=226, Expect=2e-66]; ENSMUSG00000021583, Erap1, endoplasmic reticulum aminopeptidase 1, [Score=224, Expect=1e-62]; ENSMUSG00000039062, Anpep, alanyl (membrane) aminopeptidase, [Score=223, Expect=3e-62]} {Dmel: FBgn0039656, CG11951, [Score=283, Expect=1e-84]} {Celegans: WBGene00011587, T07F10.1, Aminopeptidase, [Score=215, Expect=1e-59]} {Smed: dd_Smed_v6_6470_0_1, dd_Smed_v6_6470_0_1, [Score=256, Expect=5e-74]} {RNA1509_48214, RNA1509_6569} {RNA1310_3710.1, RNA1509_48214} {RNA1509_48214, RNA815_5591.1} |
68. | MligTC455_27802 | 89 | 1.86 | Mlig455_057249 | Neo: - Age: - |
0.955 | - | - | - | - | - | 0.955 | Mlig455_057249 {REF} {Length: 8422} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=129.4]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=114.3]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=79.3]; Integrase zinc binding domain [PF17921.3, score=71.9]; Integrase core domain [PF00665.28, score=47.6]; Aspartyl protease [PF13650.8, score=39.7]; gag-polyprotein putative aspartyl protease [PF13975.8, score=35.0]; Retroviral aspartyl protease [PF00077.22, score=28.6]; Aspartyl protease [PF09668.12, score=23.4]; Putative peptidase (DUF1758) [PF05585.14, score=22.5]; Retroviral aspartyl protease [PF08284.13, score=19.6]; DDE superfamily endonuclease [PF13358.8, score=19.1]} {Smed: dd_Smed_v6_1574_6_40, dd_Smed_v6_1574_6_40, [Score=342, Expect=8e-103]} {RNA1509_28802} {RNA1310_131.1} {RNA815_52.1} | |
69. | MligTC455_38059 | 120 | 2.49 | Mlig455_014851 | Neo: - Age: - |
0.955 | - | - | - | - | - | 0.955 | Mlig455_014851 {REF} {Length: 6091} {RNA1509_53932} {RNA1310_7589} {RNA815_18106} | |
70. | MligTC455_42682 | 45 | 0.93 | Mlig455_010400 | Neo: - Age: - |
0.955 | - | - | - | - | - | 0.955 | Mlig455_010400 {REF} {Length: 1751} {NoTransDecoderORF} {RNA1509_58929} {RNA1310_128448} {RNA815_10390} | |
71. | MligTC455_53118 | 133 | 2.76 | Mlig455_029477 | Neo: - Age: - |
CHRNA2 | 0.955 | - | - | - | - | - | 0.955 | Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334} |
72. | MligTC455_51319 | 50 | 1.04 | Mlig455_050267 | Neo: - Age: - Region-enriched R4: 4.268/0.03200 |
RAD51C | 0.954 | - | - | - | - | - | 0.954 | Mlig455_050267 {REF} {Length: 1379} {TRANSSPLICED} {Pfam: Rad51 [PF08423.13, score=138.4]; AAA domain [PF13481.8, score=35.5]; KaiC [PF06745.15, score=18.8]} {Human: ENSG00000108384, RAD51C, RAD51 paralog C, [RH, Score=179, Expect=3e-52]} {Mouse: ENSMUSG00000007646, Rad51c, RAD51 paralog C, [RH, Score=179, Expect=1e-52]} {Dmel: FBgn0003482, spn-D, spindle D, [RH, Score=110, Expect=1e-27]} {Celegans: WBGene00004297, rad-51, RAD51 short isoform; RecA/Rad51/Dmc1-like protein, [Score=70.5, Expect=3e-13]} {Smed: dd_Smed_v6_16724_0_2, dd_Smed_v6_16724_0_2, [RH, Score=183, Expect=3e-55]} {RNA1509_27617} {RNA1310_25633.1, RNA1509_27617} {RNA1509_27617, RNA815_20829} |
73. | MligTC455_11844 | 12 | 0.25 | Mlig455_035140 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_035140 {REF} {Length: 439} {NoTransDecoderORF} {RNA1310_130188} | |
74. | MligTC455_12197 | 252 | 5.26 | Mlig455_017087 | Neo: - Age: Down-Down-Up Region-enriched R5: 1.888/0.03999 |
CXorf65 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_017087 {REF} {Length: 1998} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=80.7]} {Human: ENSG00000204165, CXorf65, chromosome X open reading frame 65, [Score=45.8, Expect=5e-06]} {Mouse: ENSMUSG00000090141, Gm614, predicted gene 614, [Score=48.9, Expect=3e-07]} {RNA1509_30706} {RNA1310_4498.2} {RNA815_1649} |
75. | MligTC455_14677 | 21 | 0.44 | Mlig455_004558, Mlig455_064752 | Neo: - Age: - |
TRPM2 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_004558 {REF} {Length: 1754} {Pfam: SLOG in TRPM [PF18139.3, score=98.9]; Ankyrin repeats (3 copies) [PF12796.9, score=36.5]; Ankyrin repeat [PF13606.8, score=23.8]; Ankyrin repeat [PF00023.32, score=22.8]; Ankyrin repeats (many copies) [PF13857.8, score=20.3]; Ankyrin repeats (many copies) [PF13637.8, score=20.1]} {Human: ENSG00000142185, TRPM2, transient receptor potential cation channel subfamily M member 2, [Score=134, Expect=1e-32]} {Mouse: ENSMUSG00000009292, Trpm2, transient receptor potential cation channel, subfamily M, member 2, [Score=126, Expect=4e-30]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=82.0, Expect=5e-16]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_17981_0_3, dd_Smed_v6_17981_0_3, [Score=157, Expect=3e-41]} {RNA1310_103417} Mlig455_064752 {REF} {Length: 2527} {Pfam: SLOG in TRPM [PF18139.3, score=98.9]; Ankyrin repeats (3 copies) [PF12796.9, score=37.5]; Ankyrin repeat [PF13606.8, score=26.1]; Ankyrin repeats (many copies) [PF13637.8, score=25.3]; Ankyrin repeats (many copies) [PF13857.8, score=24.8]; Ankyrin repeat [PF00023.32, score=23.9]} {Human: ENSG00000142185, TRPM2, transient receptor potential cation channel subfamily M member 2, [Score=135, Expect=5e-33]} {Mouse: ENSMUSG00000009292, Trpm2, transient receptor potential cation channel, subfamily M, member 2, [Score=128, Expect=1e-30]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=82.4, Expect=5e-16]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=96.3, Expect=2e-20]} {Smed: dd_Smed_v6_17981_0_3, dd_Smed_v6_17981_0_3, [Score=157, Expect=4e-41]} {RNA1509_36146} {RNA1310_103417} {RNA815_131.5} |
76. | MligTC455_14961 | 39 | 0.82 | Mlig455_048867 | Neo: - Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_048867 {REF} {Length: 979} {NoTransDecoderORF} {RNA1310_98124} | |
77. | MligTC455_19130 | 1367 | 28.48 | Mlig455_026706 | Neo: - Age: Down-Up-Down Regeneration-upregulated BL: 2.447 Regeneration-enriched BL: 2.447 |
METTL27 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_026706 {REF} {Length: 1369} {Pfam: Methyltransferase domain [PF13649.8, score=31.4]} {Human: ENSG00000165171, METTL27, methyltransferase like 27, [Score=85.5, Expect=1e-19]} {Mouse: ENSMUSG00000040557, Mettl27, methyltransferase like 27, [Score=85.1, Expect=1e-19]} {Smed: dd_Smed_v6_5408_0_1, dd_Smed_v6_5408_0_1, [RH, Score=154, Expect=6e-47]} {RNA1509_29375} {RNA1310_31403.1, RNA1509_29375} {RNA1509_29375, RNA815_12596} |
78. | MligTC455_27846 | 65 | 1.35 | Mlig455_062268 | Neo: - Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_062268 {REF} {Length: 6610} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=128.3]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=113.8]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=76.6]; Integrase zinc binding domain [PF17921.3, score=71.0]; Integrase core domain [PF00665.28, score=47.5]; Aspartyl protease [PF13650.8, score=38.9]; gag-polyprotein putative aspartyl protease [PF13975.8, score=34.5]; Retroviral aspartyl protease [PF00077.22, score=26.8]; Aspartyl protease [PF09668.12, score=22.8]; Putative peptidase (DUF1758) [PF05585.14, score=21.8]; Retroviral aspartyl protease [PF08284.13, score=18.9]; DDE superfamily endonuclease [PF13358.8, score=18.6]} {Smed: dd_Smed_v6_1574_6_41, dd_Smed_v6_1574_6_41, [Score=335, Expect=6e-100]} {RNA1509_20493} {RNA1310_131.1} {RNA815_52.1} | |
79. | MligTC455_42723 | 666 | 13.88 | Mlig455_069654 | Neo: Irradiation Age: - Region-enriched R7: 2.955/0.00360 Regeneration-upregulated BL: 3.069 Regeneration-enriched BL: 3.069 |
0.953 | - | - | - | - | - | 0.953 | Mlig455_069654 {REF} {Length: 1471} {RNA1310_30663.1} {RNA815_50207} | |
80. | MligTC455_20573 | 63 | 1.31 | Mlig455_058491 | Neo: Int S/G2/M Age: - |
ATP6V1FNB | 0.952 | - | - | - | - | - | 0.952 | Mlig455_058491 {REF} {Length: 3487} {Pfam: FAM183A and FAM183B related [PF14886.8, score=22.5]} {Human: ENSG00000272899, ATP6V1FNB, ATP6V1F neighbor, [RH, Score=65.1, Expect=4e-12]} {Mouse: ENSMUSG00000109649, Gm45521, predicted gene 45521, [RH, Score=91.7, Expect=1e-21]} {Smed: dd_Smed_v6_3203_0_1, dd_Smed_v6_3203_0_1, [Score=132, Expect=2e-37]} {RNA1509_40833} {RNA1310_10710.1} {RNA815_4442.1} |
81. | MligTC455_29468 | 155 | 3.23 | Mlig455_038395, Mlig455_038601 | Neo: - Age: Up-Up-Down Region-enriched R7: 4.536/0.00000 |
SVEP1 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_038395 {REF} {Length: 1918} {RNA1310_21924} {RNA815_33621} Mlig455_038601 {REF} {Length: 3532} {Pfam: Tyrosine-protein kinase ephrin type A/B receptor-like [PF07699.15, score=81.8]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=48.0]; TNFR/NGFR cysteine-rich region [PF00020.20, score=28.9]} {Human: ENSG00000165124, SVEP1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=55.8, Expect=1e-08]} {Mouse: ENSMUSG00000028369, Svep1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=52.8, Expect=9e-08]; ENSMUSG00000109446, Gm9195, predicted gene 9195, [Score=50.8, Expect=4e-07]} {Dmel: FBgn0031879, uif, uninflatable, [Score=50.1, Expect=5e-07]} {Smed: dd_Smed_v6_3432_0_1, dd_Smed_v6_3432_0_1, [Score=90.9, Expect=7e-22]} {RNA1310_21924} {RNA815_16704} |
82. | MligTC455_38984 | 42 | 0.88 | Mlig455_049162 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_049162 {REF} {Length: 684} {NoTransDecoderORF} {RNA1509_5313} {RNA1310_1658.1} {RNA815_28415} | |
83. | MligTC455_40913 | 85 | 1.77 | Mlig455_067935 | Neo: - Age: - Regeneration-upregulated BL: 9.167 Regeneration-enriched BL: 9.167 |
ASCL5 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_067935 {REF} {Length: 1417} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=44.2]} {Human: ENSG00000232237, ASCL5, achaete-scute family bHLH transcription factor 5, [Score=48.1, Expect=4e-06]; ENSG00000176009, ASCL3, achaete-scute family bHLH transcription factor 3, [Score=47.0, Expect=7e-06]} {Mouse: ENSMUSG00000097918, Ascl5, achaete-scute family bHLH transcription factor 5, [Score=48.5, Expect=2e-06]} {Dmel: FBgn0004170, sc, scute, [Score=55.1, Expect=2e-08]} {Celegans: WBGene00001950, hlh-3, Helix-loop-helix protein 3, [Score=47.0, Expect=3e-06]} |
84. | MligTC455_10259 | 124 | 2.58 | Mlig455_052843 | Neo: Int S/G2/M Age: - |
0.951 | - | - | - | - | - | 0.951 | Mlig455_052843 {REF} {Length: 1170} {RNA1310_32241.1} {RNA815_32339} | |
85. | MligTC455_18247 | 30 | 0.63 | Mlig455_064217 | Neo: - Age: - |
RASEF | 0.951 | - | - | - | - | - | 0.951 | Mlig455_064217 {REF} {Length: 2591} {Pfam: Ras family [PF00071.24, score=148.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=96.7]; ADP-ribosylation factor family [PF00025.23, score=52.9]; EF-hand domain pair [PF13499.8, score=33.8]; EF-hand domain [PF13405.8, score=31.5]; EF hand [PF00036.34, score=30.7]; 50S ribosome-binding GTPase [PF01926.25, score=23.7]; Elongation factor Tu GTP binding domain [PF00009.29, score=23.0]; EF hand [PF13202.8, score=20.1]; EF-hand domain pair [PF13833.8, score=18.9]} {Human: ENSG00000165105, RASEF, RAS and EF-hand domain containing, [Score=172, Expect=1e-44]; ENSG00000130038, CRACR2A, calcium release activated channel regulator 2A, [Score=169, Expect=2e-43]} {Mouse: ENSMUSG00000043003, Rasef, RAS and EF hand domain containing, [Score=180, Expect=5e-48]} {Dmel: FBgn0005586, Rab3, [Score=129, Expect=8e-34]} {Celegans: WBGene00016344, rsef-1, Ras and EF-hand domain-containing protein homolog, [Score=174, Expect=7e-46]} {Smed: dd_Smed_v6_12567_0_1, dd_Smed_v6_12567_0_1, [Score=207, Expect=8e-58]} {RNA1310_62867} |
86. | MligTC455_22964 | 20 | 0.42 | Mlig455_033179 | Neo: Irradiation Age: logFC(26M/2M)=0.775 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_033179 {REF} {Length: 3668} {TRANSSPLICED} {Pfam: Autophagy protein 16 (ATG16) [PF08614.13, score=55.4]; Fez1 [PF06818.17, score=33.5]; Ezrin/radixin/moesin family [PF00769.21, score=28.5]; Crescentin protein [PF19220.2, score=27.2]; Intermediate filament protein [PF00038.23, score=25.1]; Tropomyosin like [PF12718.9, score=20.0]; Arabidopsis phospholipase-like protein (PEARLI 4) [PF05278.14, score=19.3]; Myosin tail [PF01576.21, score=17.6]} {RNA1509_7077} {RNA1310_18593.1, RNA1509_7077} {RNA1509_7077, RNA815_1697} | |
87. | MligTC455_08498 | 26 | 0.55 | Mlig455_053380 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_053380 {REF} {Length: 962} {NoTransDecoderORF} {RNA1310_91082} | |
88. | MligTC455_14502 | 32 | 0.67 | Mlig455_047308 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_047308 {REF} {Length: 1018} {TRANSSPLICED} {RNA1509_56030} {RNA1310_23619} {RNA815_11671} | |
89. | MligTC455_33212 | 61 | 1.27 | Mlig455_003428 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_003428 {REF} {Length: 1700} {NoTransDecoderORF} {RNA1509_44389} {RNA1310_14765.1} {RNA815_7155} |